103 245

Cited 10 times in

Clinical implications and diagnostic usefulness of correlation between soluble major Histocompatibility Complex Class I Chain-Related Molecule A and Protumorigenic Cytokines in Pancreatic Ductal Adenocarcinoma

 Hye Won Chung  ;  Sunphil Jang  ;  Jong-Baeck Lim 
 CANCER, Vol.119(1) : 233-244, 2013 
Journal Title
Issue Date
Carcinoma, Pancreatic Ductal/blood ; Carcinoma, Pancreatic Ductal/diagnosis* ; Carcinoma, Pancreatic Ductal/pathology ; Cytokines/blood* ; Female ; Histocompatibility Antigens Class I/blood* ; Humans ; Male ; Neoplasm Metastasis ; Pancreatic Neoplasms/blood ; Pancreatic Neoplasms/diagnosis* ; Pancreatic Neoplasms/pathology
cytokines ; diagnostic accuracy ; pancreatic ductal adenocarcinoma ; relationship ; soluble major histocompatibility ; complex class I chain-related molecule A
BACKGROUND: Tumor-derived soluble factors serve as mediators between tumors and surrounding microenvironment to promote tumor growth and metastasis under a complex network. The objective of this study was to evaluate the relationships between soluble major histocompatibility complex class I chain-related molecule A (sMICA) and 4 categories of cytokines (tumor-related proinflammatory, anti-inflammatory, chemotactic/proangiogenic, and growth-stimulatory) in the development and progression of pancreatic ductal adenocarcinoma (PDAC). METHODS: Serum levels of sMICA and 4-categorized cytokines were measured by enzyme-linked immunosorbent assay and chemiluminescent immunoassay, respectively, in 134 individuals (normal, n = 55; chronic pancreatitis, n = 25; PDAC, n = 54). Clinical implications of sMICA and tumor-related cytokines, their correlations, and diagnostic usefulness in PDAC were evaluated. RESULTS: Serum sMICA, which was associated with the development and progression of PDAC, correlated with interferon-γ negatively (P = 0.024), whereas it correlated positively with the anti-inflammatory cytokines interleukin-10 (IL-10) and IL-1 receptor antagonist, and the bifunctional cytokine tumor necrosis factor α, with respect to PDAC development (P < .05). sMICA also correlated positively with the chemotactic/proangiogenic cytokines vascular endothelial growth factor, soluble CD40 ligand, and IL-8, and the tumor growth-stimulatory cytokines epidermal growth factor and transforming growth factor α, with respect to PDAC development and/or progression. Logistic regression analysis validated the diagnostic usefulness of combination use of sMICA and its related cytokines to predict the presence of PDAC and distant metastasis in PDAC, superior to carbohydrate antigen 19-9. CONCLUSIONS: sMICA may be involved in tumor-associated angiogenesis and tumor growth either directly or indirectly by affecting corresponding cytokines as well as causing impairment of natural killer cell cytotoxicity in the development and progression of PDAC. A combination of sMICA and its related cytokines exhibited remarkable diagnostic potential in PDAC.
Files in This Item:
T201300268.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Laboratory Medicine (진단검사의학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers
Yonsei Authors
Lim, Jong Baeck(임종백) ORCID logo https://orcid.org/0000-0003-0419-0422
Jang, Sun Phil(장선필)
Chung, Hye Won(정혜원)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.